A little-studied steroid that serves as a building block for hormones like estrogen and testosterone has been shown to enhance learning and memory in a new study by researchers at UC San Francisco.

The discovery could offer a new path toward treatments for neurodegeneration, schizophrenia and depression, conditions that affect millions of Americans.

In a first, scientists at UCSF and Stanford identified genetic variants that predict whether a patient is likely to respond to treatment for preterm birth. Screening for mutations could allow doctors to target medications to those most likely to benefit. No medication is currently available in the U.S. to treat preterm birth.

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug.

A study of seriously ill patients from academic medical centers across the country has found that nearly a quarter had a delayed or missed diagnosis.

The Danaher-IGI Beacon for CRISPR Cures center will use genome editing to address potentially hundreds of diseases, including rare genetic disorders that have no cure, to ensure treatments can be developed and brought to patients more quickly and efficiently.